Tranquilli A L, Conti C, Rezai B, Garzetti G G, Romanini C
Department of Obstetrics and Gynecology, University of Ancona, Italy.
Clin Exp Obstet Gynecol. 1994;21(1):45-8.
We assessed the action of nifedipine on vascular reactivity to angiotensin II (AII) in pregnant women at risk for hypertension.
We studied eleven pregnant women (28-32 weeks' gestation) who had shown a 20 mmHg increase in basal diastolic blood pressure at AII infusion rates < 10 ng/kg/min (Effective pressor dose, EPD), and were therefore considered at high risk for the subsequent development of pregnancy-induced hypertension, according to Gant. After the AII infusion was completed, we allowed the patients 4 hours of rest to avoid interactions with the first test, then administered 10 mg nifedipine, and after 30 minutes repeated the test.
In all the 11 women the EPD after nifedipine administration had significantly reverted to normal (paired t-test: p < 0.03).
The efficacy of nifedipine in reducing the pressor response to AII suggests the involvement of intracellular free calcium in the vascular response to pressor agents in pregnancy, and supports the use of this drug in the treatment of pregnancy-induced hypertension.
我们评估了硝苯地平对有高血压风险的孕妇血管对血管紧张素II(AII)反应性的作用。
我们研究了11名孕妇(妊娠28 - 32周),这些孕妇在AII输注速率<10 ng/kg/min时基础舒张压升高了20 mmHg(有效升压剂量,EPD),因此根据甘特标准被认为随后发生妊娠高血压的风险很高。在AII输注完成后,我们让患者休息4小时以避免与第一次测试相互作用,然后给予10 mg硝苯地平,30分钟后重复测试。
在所有11名女性中,服用硝苯地平后的EPD显著恢复正常(配对t检验:p < 0.03)。
硝苯地平降低对AII升压反应的功效表明细胞内游离钙参与了妊娠期间血管对升压剂的反应,并支持使用该药物治疗妊娠高血压。